121 related articles for article (PubMed ID: 38278138)
1. Self-Supplied Reactive Oxygen Species-Responsive Mitoxantrone Polyprodrug for Chemosensitization-Enhanced Chemotherapy under Moderate Hyperthermia.
Zhang H; Wang J; Wu R; Zheng B; Sang Y; Wang B; Song L; Hu Y; Ma X
Adv Healthc Mater; 2024 May; 13(12):e2303631. PubMed ID: 38278138
[TBL] [Abstract][Full Text] [Related]
2. A polyprodrug-based nanoplatform for cisplatin prodrug delivery and combination cancer therapy.
Lin C; Tao Y; Saw PE; Cao M; Huang H; Xu X
Chem Commun (Camb); 2019 Nov; 55(93):13987-13990. PubMed ID: 31687673
[TBL] [Abstract][Full Text] [Related]
3. Magnetically modified-mitoxantrone mesoporous organosilica drugs: an emergent multimodal nanochemotherapy for breast cancer.
Romaní-Cubells E; Martínez-Erro S; Morales V; Chocarro-Calvo A; García-Martínez JM; Sanz R; García-Jiménez C; García-Muñoz RA
J Nanobiotechnology; 2024 May; 22(1):249. PubMed ID: 38745193
[TBL] [Abstract][Full Text] [Related]
4. A novel ROS-activable self-immolative prodrug for tumor-specific amplification of oxidative stress and enhancing chemotherapy of mitoxantrone.
Zhang H; Chen W; Wang J; Du W; Wang B; Song L; Hu Y; Ma X
Biomaterials; 2023 Feb; 293():121954. PubMed ID: 36538847
[TBL] [Abstract][Full Text] [Related]
5. Intracellular Self-Immolative Polyprodrug with Near-Infrared Light Guided Accumulation and in Vivo Visualization of Drug Release.
Cheng DB; Zhang XH; Chen SY; Xu XX; Wang H; Qiao ZY
Adv Mater; 2022 Mar; 34(9):e2109528. PubMed ID: 34933400
[TBL] [Abstract][Full Text] [Related]
6. Glutathione-depleting polyprodrug nanoparticle for enhanced photodynamic therapy and cascaded locoregional chemotherapy.
Zhang X; Zhang X; Chen S; Liu Y; Cao C; Cheng G; Wang S
J Colloid Interface Sci; 2024 Sep; 670():279-287. PubMed ID: 38763024
[TBL] [Abstract][Full Text] [Related]
7. Acid-responsive nanoparticles as a novel oxidative stress-inducing anticancer therapeutic agent for colon cancer.
Zhao C; Cao W; Zheng H; Xiao Z; Hu J; Yang L; Chen M; Liang G; Zheng S; Zhao C
Int J Nanomedicine; 2019; 14():1597-1618. PubMed ID: 30880968
[TBL] [Abstract][Full Text] [Related]
8. Cinnamaldehyde-Based Poly(ester-thioacetal) To Generate Reactive Oxygen Species for Fabricating Reactive Oxygen Species-Responsive Nanoparticles.
Xu L; Zhao M; Zhang H; Gao W; Guo Z; Zhang X; Zhang J; Cao J; Pu Y; He B
Biomacromolecules; 2018 Dec; 19(12):4658-4667. PubMed ID: 30418756
[TBL] [Abstract][Full Text] [Related]
9. Glutathione and Reactive Oxygen Species Dual-Responsive Block Copolymer Prodrugs for Boosting Tumor Site-Specific Drug Release and Enhanced Antitumor Efficacy.
Yin W; Ke W; Lu N; Wang Y; Japir AAMM; Mohammed F; Wang Y; Pan Y; Ge Z
Biomacromolecules; 2020 Feb; 21(2):921-929. PubMed ID: 31961134
[TBL] [Abstract][Full Text] [Related]
10. Efficacy-shaping nanomedicine by loading Calcium Peroxide into Tumor Microenvironment-responsive Nanoparticles for the Antitumor Therapy of Prostate Cancer.
Wu D; Zhu ZQ; Tang HX; Shi ZE; Kang J; Liu Q; Qi J
Theranostics; 2020; 10(21):9808-9829. PubMed ID: 32863961
[No Abstract] [Full Text] [Related]
11. Hyaluronic Acid-Bilirubin Nanoparticles as a Tumor Microenvironment Reactive Oxygen Species-Responsive Nanomedicine for Targeted Cancer Therapy.
Lee S; Lee SA; Shinn J; Lee Y
Int J Nanomedicine; 2024; 19():4893-4906. PubMed ID: 38828202
[TBL] [Abstract][Full Text] [Related]
12. Enhanced Antitumor Efficacy by a Cascade of Reactive Oxygen Species Generation and Drug Release.
Wang S; Yu G; Wang Z; Jacobson O; Lin LS; Yang W; Deng H; He Z; Liu Y; Chen ZY; Chen X
Angew Chem Int Ed Engl; 2019 Oct; 58(41):14758-14763. PubMed ID: 31429173
[TBL] [Abstract][Full Text] [Related]
13. Selective self-induced stimulus amplification prodrug platform for inhibiting multidrug resistance and lung metastasis.
Xu C; Sun Y; Qi Y; Yu Y; He Y; Hu M; Hu Q; Wu T; Zhang D; Shang L; Deng H; Zhang Z
J Control Release; 2018 Aug; 284():224-239. PubMed ID: 29958912
[TBL] [Abstract][Full Text] [Related]
14. Self-boosting stimulus activation of a polyprodrug with cascade amplification for enhanced antitumor efficacy.
Zong Q; Xiao X; Li J; Yuan Y
Biomater Sci; 2022 Jul; 10(15):4228-4234. PubMed ID: 35758299
[TBL] [Abstract][Full Text] [Related]
15. Self-immolative polyprodrug-based tumor-specific cascade amplificated drug release nanosystem for orchestrated synergistic cancer therapy.
Wang K; Xiao X; Liu Y; Zong Q; Tu Y; Yuan Y
Biomaterials; 2022 Oct; 289():121803. PubMed ID: 36150300
[TBL] [Abstract][Full Text] [Related]
16. ROS-Activated homodimeric podophyllotoxin nanomedicine with self-accelerating drug release for efficient cancer eradication.
Liang B; Zhou D
Drug Deliv; 2021 Dec; 28(1):2361-2372. PubMed ID: 34747277
[TBL] [Abstract][Full Text] [Related]
17. Polyprodrug nanomedicine for chemiexcitation-triggered self-augmented cancer chemotherapy and gas therapy.
Wang Q; Zhang C; Zhao Y; Jin Y; Zhou S; Qin J; Zhang W; Hu Y; Chen X; Yang K
Biomaterials; 2024 Sep; 309():122606. PubMed ID: 38776593
[TBL] [Abstract][Full Text] [Related]
18. Mitochondria-specific drug release and reactive oxygen species burst induced by polyprodrug nanoreactors can enhance chemotherapy.
Zhang W; Hu X; Shen Q; Xing D
Nat Commun; 2019 Apr; 10(1):1704. PubMed ID: 30979885
[TBL] [Abstract][Full Text] [Related]
19. Chitosan derivatives functionalized dual ROS-responsive nanocarriers to enhance synergistic oxidation-chemotherapy.
Liao JX; Huang QF; Li YH; Zhang DW; Wang GH
Carbohydr Polym; 2022 Apr; 282():119087. PubMed ID: 35123755
[TBL] [Abstract][Full Text] [Related]
20. Nanostructured lipid-carrageenan hybrid carriers (NLCCs) for controlled delivery of mitoxantrone hydrochloride to enhance anticancer activity bypassing the BCRP-mediated efflux.
Ling G; Zhang T; Zhang P; Sun J; He Z
Drug Dev Ind Pharm; 2016 Aug; 42(8):1351-9. PubMed ID: 26754913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
